BRIEF published on 08/06/2024 at 09:50, 2 years 1 month ago Computacenter Certified Among the Best Places to Work in Romania for 2024-2025 Best Places To Work Romania Employee Well-being Workplace Culture Computacenter
BRIEF published on 08/06/2024 at 09:50, 2 years 1 month ago Computacenter certifié parmi les meilleurs lieux de travail en Roumanie pour 2024-2025 Roumanie Culture Du Lieu De Travail Bien-être Des Employés Meilleurs Endroits Où Travailler Centre De Calcul
BRIEF published on 08/06/2024 at 09:47, 2 years 1 month ago USU Achieves SAP® Certified Integration with RISE with SAP S/4HANA® Cloud USU Software AG Software Asset Management SAP Certification RISE With SAP S/4HANA Cloud Integration
BRIEF published on 08/06/2024 at 09:47, 2 years 1 month ago L'USU obtient l'intégration certifiée SAP® avec RISE avec SAP S/4HANA® Cloud USU Software AG Gestion Des Actifs Logiciels Certification SAP ÉLEVEZ-VOUS Avec SAP S/4HANA Intégration Cloud
BRIEF published on 08/06/2024 at 09:35, 2 years 1 month ago Advanced Blockchain AG Announces New Management Board Team Investor Relations Management Board Web3 Blockchain Industry Advanced Blockchain AG
BRIEF published on 08/06/2024 at 09:35, 2 years 1 month ago Advanced Blockchain AG annonce la nouvelle équipe du conseil d'administration Conseil D'administration Web3 Relations Avec Les Investisseurs Blockchain Avancée AG Industrie De La Blockchain
BRIEF published on 08/06/2024 at 09:06, 2 years 1 month ago Original-Research: LAIQON AG Receives "BUY" Recommendation from NuWays AG Investment Capital Increase NuWays AG LAIQON AG Undervalued
BRIEF published on 08/06/2024 at 09:06, 2 years 1 month ago Recherche originale : LAIQON AG reçoit la recommandation « ACHETER » de NuWays AG Investissement Augmentation De Capital LAIQON AG NuWays SA Sous-évalué
BRIEF published on 08/06/2024 at 09:05, 2 years 1 month ago Biotest Sees 35% Sales Spike in First Half of 2024 Financial Results Revenue Growth FDA Approval Biotest Yimmugo®
BRIEF published on 08/06/2024 at 09:05, 2 years 1 month ago Biotest voit ses ventes augmenter de 35 % au premier semestre 2024 Résultats Financiers Hausse Des Revenus Approbation De La FDA Biotest Yimmugo®
Published on 09/11/2026 at 04:00, 4 hours 57 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 10 hours 32 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 37 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 17 hours 57 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 08:15, 41 minutes ago EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Published on 09/11/2026 at 08:02, 54 minutes ago PUMA CCO Matthias Baeumer to step down from Management Board
Published on 09/11/2026 at 07:30, 1 hour 26 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 8 hours 51 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 07:00, 1 hour 57 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 hour 57 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 27 minutes ago Availability of the 2026 Interim Financial Report
